Bladder Cancer: Management and Future Directions
نویسندگان
چکیده
Christopher P. Evans *, Frans M.J. Debruyne , Heather Payne , Eduardo Solsona , Pierre Teillac , Andrea Tubaro f Department of Urology, University of California, Sacramento, CA, United States Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom Department of Urology, Instituto Valenciano de Oncologia, Valencia, Spain Saint Louis Hospital, Paris, France Department of Urology, 2nd School of Medicine, ‘La Sapienza’ University–Sant’Andrea Hospital, Rome, Italy avai lab le at www.sciencedi rect .com journa l homepage: www.europeanurology.com
منابع مشابه
Future directions in bladder cancer immunotherapy: towards adaptive immunity.
The clinical management of bladder cancer has not changed significantly in several decades. In particular, intravesical bacillus Calmette-Guérin (BCG) immunotherapy has been a mainstay for high-risk nonmuscle invasive bladder cancer since the late 1970s/early 1980s. This is despite the fact that bladder cancer has the highest recurrence rates of any cancer and BCG immunotherapy has not been sho...
متن کاملGERIATRIC UROLOGY (TJ GUZZO, SECTION EDITOR) Optimal Management of the Elderly Patient with Muscle-Invasive Bladder Cancer
With the growing elderly demographic and the peak incidence of bladder cancer being approximately 70 years old, an increasing number of elderly patients will develop invasive bladder cancer. Several studies suggest that a survival gap exists between elderly patients with invasive bladder cancer and younger cohorts. Radical cystectomy is the standard of care that provides good cancer-specific su...
متن کاملMetastatic Bladder Cancer: A Review of Current Management
Bladder cancer continues to result in substantial morbidity and mortality for affected individuals. Advances in the management of metastatic bladder cancer have been limited. Chemotherapy with platinum-based regimes remains the mainstay of first-line treatment. Studies investigating alternative regimes have offered no survival advantage. Targeted therapies may offer benefit either as single age...
متن کاملDecentralisation, Decision Space and Directions for Future Research; Comment on “Decentralisation of Health Services in Fiji: A Decision Space Analysis”
Decentralisation continues to re-appear in health system reform across the world. Evaluation of these reforms reveals how research on decentralisation continues to evolve. In this paper, we examine the theoretical foundations and empirical references which underpin current approaches to studying decentralisation in health systems.
متن کاملEditorial Report of fifteen years contributions to radiological sciences: Future directions and prospects
At the close of the 20th century, fundamental discoveries changed broadly the worlds of physics, biology and medicine. The rapid advancements achieved during recent years, mainly due to revolutionary methodological improvements, have led to an unparalleled explosion of information; often appear to overshadow the earlier works. However as more basic discoveries are made these separate scientific...
متن کاملMicroRNAs as biomarkers associated with bladder cancer
Bladder cancer is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs are emerging as diagnostic biomarkers for bladder cancer. Specific miRNA profiles have been identified for several samples from patients with bladder cancer. MicroRNAs are noncoding RNA molecules of approximately 23 nucleotides that play important roles...
متن کامل